Status:
UNKNOWN
"Iron Overload and Endocrinological Diseases"
Lead Sponsor:
Azienda Ospedaliero-Universitaria di Modena
Conditions:
Iron Overload
Thalassemia Major
Eligibility:
All Genders
18-65 years
Brief Summary
Patients with hemochromatosis or Thalassemia develop progressive tissue and organs damages secondary to iron overload. Iron overload can result both from transfusional hemosiderosis and excess gastroi...
Eligibility Criteria
Inclusion
- Certain diagnosis of β-thalassemia major or intermedia
- Certain diagnosis of Hereditary Hemochromatosis
- Adult patients with an age between 18 and 65 years
Exclusion
- Subjects with an age \< 18 and \> 65 years
Key Trial Info
Start Date :
June 20 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT06137079
Start Date
June 20 2013
End Date
December 31 2025
Last Update
November 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Unit of Endocrinology of Azienza Ospedaliero-Universitaria di Modena
Modena, Italy